Landscapes / Companies
Chengdu Zenitar Biomedical Technology Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
2 in Phase 2
Drugs
6
in active trials · 7 in all
Trials
16 active
23 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Dec 2026Phase 2 trial completes | |||
| Next date | 30 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Diffuse Large B Cell Lymphoma,DLBCL, Advanced Solid Tumor and 5 more | ||||
| Open drug page | |||||
Flonoltinibnot checked |
Tyrosine kinase inhibitor |
Phase 3 | 30 Jul 2027Phase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | 30 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | MF, MF,PMF,PPV-MF,PET-MF and 14 more | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Dec 2027Phase 2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jun 2028Phase 1/2 trial completes | |||
| Next date | 30 Jun 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
Multiple-ascending Doses studynot checked |
— |
Phase 1 | 30 Sep 2027Phase 1 trial completes | ||
| Next date | 30 Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Obesity With Cardiovascular Risk Study | ||||
| Open drug page | |||||
Obesitynot checked |
— |
Phase 1 | 30 Sep 2027Phase 1 trial completes | ||
| Next date | 30 Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Obesity With Cardiovascular Risk Study | ||||
| Open drug page | |||||
About
- No active trial
- flunotinib
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021